Get the Stockscreener App
725.91
5.30%
36.56
Idexx Laboratories Inc stock is traded at $725.91, with a volume of 972.43K.
It is up +5.30% in the last 24 hours and up +13.93% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$689.35
Open:
$690.1
24h Volume:
972.43K
Relative Volume:
2.03
Market Cap:
$57.96B
Revenue:
$4.17B
Net Income/Loss:
$1.03B
P/E Ratio:
57.54
EPS:
12.6148
Net Cash Flow:
$940.22M
1W Performance:
+5.22%
1M Performance:
+13.93%
6M Performance:
+44.93%
1Y Performance:
+73.43%
1-Day Range:
$688.14
$735.59
1-Week Range:
$665.25
$735.59
52-Week Range:
$356.14
$735.59
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
725.91 | 55.05B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
587.48 | 215.18B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
227.39 | 156.94B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
151.25 | 41.12B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
224.90 | 36.97B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Idexx Laboratories stock hits all-time high at 735.31 USD By Investing.com - Investing.com Nigeria
Here's How Much You Would Have Made Owning IDEXX Laboratories Stock In The Last 10 Years - Benzinga
Palmetto Grain Brokerage - Palmetto Grain Brokerage
What Are Wall Street Analysts' Target Price for IDEXX Laboratories Stock? - inkl
Can IDEXX Laboratories Inc. (IX1) stock retain market dominanceWeekly Trade Analysis & Fast Exit and Entry Strategy Plans - newser.com
Is IDEXX Laboratories Inc. stock cheap at current valuationJuly 2025 Trade Ideas & Daily Stock Momentum Reports - newser.com
Why IDEXX Laboratories Inc. stock could benefit from AI revolutionWeekly Trend Summary & Risk Controlled Stock Pick Alerts - newser.com
Is IDEXX Laboratories Inc. stock attractive for ETFsCEO Change & Momentum Based Trading Signals - newser.com
Idexx Laboratories (IDXX) Recently Broke Out Above the 20-Day Moving Average - Yahoo Finance
Will IDEXX Laboratories Inc. stock outperform growth indexes2025 Top Gainers & Technical Pattern Based Signals - newser.com
How robust is IDEXX Laboratories Inc. (IX1) stock financial positionWeekly Stock Report & AI Forecasted Entry/Exit Points - newser.com
Why IDEXX Laboratories Inc. stock is a must watch in 2025Portfolio Risk Report & Intraday High Probability Alerts - newser.com
Why IDEXX Laboratories Inc. (IX1) stock stays undervaluedTrade Performance Summary & AI Powered Buy/Sell Recommendations - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveTrade Risk Assessment & Precise Entry and Exit Recommendations - newser.com
IDEXX Laboratories Inc. stock outperforms competitors on strong trading day - MarketWatch
Best Manufacturing: IDEXX Horizon Center - Engineering News-Record | ENR
Does IDEXX Laboratories Inc. fit your quant trading modelWeekly Stock Report & Risk Controlled Swing Alerts - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockWeekly Gains Report & Fast Exit Strategy with Risk Control - newser.com
William Blair Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating - 富途牛牛
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.27%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):